Mitral Valve Disease
78
17
22
31
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.4%
5 terminated out of 78 trials
86.1%
-0.4% vs benchmark
6%
5 trials in Phase 3/4
32%
10 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 31 completed trials
Clinical Trials (78)
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
LEFT ATRIAL MONITORING IN PATIENTS BEFORE AND AFTER MITRAL SURGERY - LAMBDA STUDY
Intraoperative Global Longitudinal Strain and Global Longitudinal Strain Rate as Predictors of Unfavorable Outcome in On-Pump Mitral Surgery
A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation
AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Abbott Cephea Mitral Valve Disease Registry
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
PARTNER 3 Trial - Mitral Valve in Valve
Safety and Efficacy of the CoolCryo System for Cardiac Cryoablation in the Treatment of Atrial Fibrillation
Mitral Valve Screening Survey
Autonomous Robotics for Transcatheter Cardiac Procedures
Early Feasibility Study of Surgical Implantation of a Polymer Prosthetic Mitral and Aortic Valve
Prospective Multicenter Study on Mitral Annular Disjunction
Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery
Respired Gases in Patients Post Cardiac Surgery
Non-invasive Prediction of Fluid and Noradrenaline Responsiveness Using the Carotid Wave Intensity.
Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for Surgery